UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients

Genetics in medicine, 2020-02, Vol.22 (2), p.407-415

2020

Volltextzugriff (PDF)

Somatic TP53 variants frequently confound germ-line testing results

Genetics in medicine, 2018-08, Vol.20 (8), p.809-816

2018

Volltextzugriff (PDF)

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

American journal of human genetics, 2021-03, Vol.108 (3), p.458-468

2021

Volltextzugriff (PDF)

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genetics in Medicine Open, 2023, Vol.1 (1), p.100432, Article 100432

2023

Volltextzugriff (PDF)

Genotype–phenotype associations among panel-based TP53+ subjects

Genetics in medicine, 2019-11, Vol.21 (11), p.2478-2484

2019

Volltextzugriff (PDF)

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer

Npj genomic medicine, 2022-08, Vol.7 (1), p.49-49, Article 49

2022

Volltextzugriff (PDF)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

Npj genomic medicine, 2022-06, Vol.7 (1), p.35-35, Article 35

2022

Volltextzugriff (PDF)

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Genetics in medicine, 2018-12, Vol.20 (12), p.1515-1521

2018

Volltextzugriff (PDF)

Synthesis and electrochemical evaluation of an amorphous titanium dioxide derived from a solid state precursor

Journal of power sources, 2010-04, Vol.195 (7), p.2064-2068

2010

Volltextzugriff (PDF)

Prevalence of Germline Mutations in Polyposis and Colorectal Cancer–Associated Genes in Patients With Multiple Colorectal Polyps

Clinical gastroenterology and hepatology, 2019-09, Vol.17 (10), p.2008-2015.e3

2019

Volltextzugriff (PDF)

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-19

2022

Volltextzugriff (PDF)

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.490-490

2017

Volltextzugriff (PDF)

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10525-10525

2021

Volltextzugriff (PDF)

Correction to: Pathogenic variants among females with breast cancer and a nonâbreast cancer reveal opportunities for cancer interception

Breast cancer research and treatment, 2023-07, Vol.200 (1), p.73

2023

Volltextzugriff (PDF)

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi72-vi72

2017

Volltextzugriff (PDF)

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13613-e13613

2018

Volltextzugriff (PDF)

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-09-03

2022

Volltextzugriff (PDF)

MP34-18 PERFORMANCE OF MULTIGENE PANEL TESTING IN HEREDITARY PROSTATE CANCER

The Journal of urology, 2018-04, Vol.199 (4), p.e444-e445

2018

Volltextzugriff (PDF)

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-35

2020

Volltextzugriff (PDF)

eP080 - Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S55

2021

Volltextzugriff (PDF)

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Molecular genetics and metabolism, 2021-04, Vol.132, p.S51-S52

2021

Volltextzugriff (PDF)

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S55

2021

Volltextzugriff (PDF)

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54

2021

Volltextzugriff (PDF)

eP078 - Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Molecular genetics and metabolism, 2021-04, Vol.132, p.S54-S54

2021

Volltextzugriff (PDF)

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Molecular genetics and metabolism, 2021-04, Vol.132, p.S51-S52

2021

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

ThemaGerm-Line Mutation

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients

Somatic TP53 variants frequently confound germ-line testing results

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance

P396: The need for a longitudinal digital health platform to implement large scale genomic programs

Genotype–phenotype associations among panel-based TP53+ subjects

Mutational and splicing landscape in a cohort of 43,000 patients tested for hereditary cancer

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care

Synthesis and electrochemical evaluation of an amorphous titanium dioxide derived from a solid state precursor

Prevalence of Germline Mutations in Polyposis and Colorectal Cancer–Associated Genes in Patients With Multiple Colorectal Polyps

Abstract P2-09-19: Inequitable access to genetic testing leads to missed screening and prevention opportunities for individuals at risk for hereditary breast and ovarian cancer

BAP1 tumor predisposition syndrome: Preliminary data from a laboratory-based multigene panel testing cohort

Closing the gap: Trends in inconclusive rates on hereditary cancer testing across racial/ethnic groups

Correction to: Pathogenic variants among females with breast cancer and a nonâbreast cancer reveal opportunities for cancer interception

EPID-16. HEREDITARY BRAIN TUMORS ARE MORE COMMON THAN YOU THINK: GERMLINE MUTATIONS IN BENIGN AND MALIGNANT PRIMARY BRAIN TUMORS

Increased detection of germline cancer susceptibility mutations subsequent to tumor profiling

Abstract P2-09-03: Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

MP34-18 PERFORMANCE OF MULTIGENE PANEL TESTING IN HEREDITARY PROSTATE CANCER

Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results

eP080 - Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Universal multi-gene panel testing for individuals with pheochromocytomas and paragangliomas

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

eP078 - Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

eP075 - Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

Aktive Filter

Suchergebnisse filtern